Equities analysts expect National Health Investors, Inc. (NYSE:NHI) to report $70.80 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for National Health Investors’ earnings, with estimates ranging from $70.46 million to $71.13 million. National Health Investors posted sales of $62.86 million during the same quarter last year, which suggests a positive year over year growth rate of 12.6%. The firm is scheduled to report its next quarterly earnings report on Monday, November 6th.

According to Zacks, analysts expect that National Health Investors will report full-year sales of $70.80 million for the current fiscal year, with estimates ranging from $275.00 million to $280.42 million. For the next financial year, analysts expect that the business will post sales of $304.23 million per share, with estimates ranging from $299.87 million to $312.83 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that cover National Health Investors.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The company had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. During the same quarter last year, the business earned $1.22 EPS. The firm’s revenue for the quarter was up 14.1% on a year-over-year basis.

NHI has been the subject of several research reports. Zacks Investment Research lowered shares of National Health Investors from a “buy” rating to a “sell” rating in a research report on Tuesday, July 18th. Mizuho restated a “hold” rating and set a $82.00 price objective on shares of National Health Investors in a research report on Wednesday, October 4th. SunTrust Banks, Inc. initiated coverage on shares of National Health Investors in a research report on Tuesday, October 10th. They set a “hold” rating and a $80.00 price objective for the company. BidaskClub upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 17th. Finally, KeyCorp restated a “hold” rating on shares of National Health Investors in a research report on Sunday, September 17th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $80.14.

In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 5.19% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Carroll Financial Associates Inc. purchased a new stake in National Health Investors during the second quarter valued at about $158,000. Yorktown Management & Research Co Inc purchased a new stake in National Health Investors during the second quarter valued at about $214,000. Allegis Investment Advisors LLC purchased a new stake in National Health Investors during the second quarter valued at about $216,000. Profund Advisors LLC lifted its stake in National Health Investors by 4.3% during the second quarter. Profund Advisors LLC now owns 3,126 shares of the real estate investment trust’s stock valued at $248,000 after buying an additional 130 shares in the last quarter. Finally, Teacher Retirement System of Texas lifted its stake in National Health Investors by 2.0% during the second quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock valued at $253,000 after buying an additional 62 shares in the last quarter. 69.56% of the stock is owned by institutional investors.

Shares of National Health Investors (NHI) traded down 1.0244% during mid-day trading on Tuesday, hitting $76.6665. 31,328 shares of the company traded hands. The firm has a 50-day moving average price of $78.40 and a 200 day moving average price of $77.11. National Health Investors has a 52-week low of $66.31 and a 52-week high of $81.21. The firm has a market cap of $3.14 billion, a price-to-earnings ratio of 19.6884 and a beta of 0.56.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be given a dividend of $0.95 per share. The ex-dividend date is Thursday, September 28th. This represents a $3.80 annualized dividend and a dividend yield of 4.91%. National Health Investors’s dividend payout ratio (DPR) is 97.69%.

TRADEMARK VIOLATION WARNING: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/24/70-80-million-in-sales-expected-for-national-health-investors-inc-nhi-this-quarter.html.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.